SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model

Por Sharma, Rajesh K., Srivastava, Abhishek K., Yolcu, Esma S., MacLeod, Kathryn J., Schabowsky, Rich-Henry, Madireddi, Shravan, Shirwan, Haval
Publicado em 2010

A Novel Form of 4-1BBL Has Better Immunomodulatory Activity than an Agonistic Anti-4-1BB Ab without Ab Associated Severe Toxicity

Por Schabowsky, Rich-Henry, Elpek, Kutlu G, Madireddi, Shravan, Sharma, Rajesh K, Yolcu, Esma S., Bandura-Morgan, Laura, Miller, Robert, MacLeod, Kathryn J, Mittler, Robert S., Shirwan, Haval
Publicado em 2009

4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines

Por Sharma, Rajesh K., Schabowsky, Rich-Henry, Srivastava, Abhishek K., Elpek, Kutlu G., Madireddi, Shravan, Zhao, Hong, Zhong, Zhenping, Miller, Robert W., MacLeod, Kathryn J., Yolcu, Esma S., Shirwan, Haval
Publicado em 2010